This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Santé Canada lance une consultation sur deux documents d'ébauche de lignes directrices sur les conditions pour les médicaments à usage humain et vétérinaire ainsi que les présentations de drogues basées sur des preuves prometteuses d'efficacité clinique

Conformément à ce que nous avons indiqué dans notre publication de décembre 2024, Santé Canada a publié ses modifications à apporter...

Canada Healthcare

SB

Smart & Biggar

Proposal For Modernizing Clinical Trial Framework Aims To Improve Access To New And Innovative Therapies In Canada

On December 20, 2025, Health Canada launched a consultation on modernizing the framework for clinical trials involving drugs for human use, including pharmaceuticals, biologics, radiopharmaceuticals, and cannabis.

Canada Healthcare

SB

Smart & Biggar

Une proposition de modernisation du cadre des essais cliniques pour favoriser l'accès à de nouvelles thérapies innovantes au Canada

Le 20 décembre 2025, Santé Canada a lancé une consultation sur la modernisation du cadre des essais cliniques visant les médicaments destinés à l'usage des humains...

Canada Healthcare

SB

Smart & Biggar

Abbott v. London Health Sciences Centre: Ontario Court Of Appeal Reaffirms The Authority Of Hospital Boards To Manage Resources

A group of dental surgeons appealed a hospital board's decision to cancel their operating room access, arguing they weren't provided with procedural fairness, including proper notice.

Canada Healthcare

OH

Osler, Hoskin & Harcourt LLP

Cancer-linked Drug And Product Lawsuits: Legal Pathways For Affected Patients

Canada Healthcare

SL

Siskinds LLP

Naming Natural Health Products: Branding In A Grey Zone

Canada Healthcare

ML

McMillan LLP

Health Canada Consultation On Two Draft Guidance Documents On Terms And Conditions For Human And Veterinary Drugs And Drug Submissions Based On Promising Evidence Of Clinical Efficacy

Canada Healthcare

SB

Smart & Biggar

Supreme Court Of Canada Affirms Immunity From Arrest In S.4.1(2) Of The Controlled Drugs And Substances Act

Canada Healthcare

AH

Alexander Holburn Beaudin + Lang LLP

British Columbia Enacts Bill 24 To Recoup Vaping-related Health Care Costs

Canada Healthcare

TL

Torys LLP

VC Investment In Canada For Life Sciences Companies

Canada Healthcare

MT

McCarthy Tétrault LLP

Taking Action On Food Insecurity

Canada Healthcare

ML

McMillan LLP

Mise à jour sur le CEPMB : Entrée en vigueur des Lignes directrices pour le personnel du CEPMB le 1er janvier 2026 et Rapport annuel 2024

Canada Healthcare

SB

Smart & Biggar

PMPRB Update: Guidelines For PMPRB Staff Come Into Effect January 1, 2026; 2024 Annual Report

Canada Healthcare

SB

Smart & Biggar

Medical Devices Updates: Phase II Consultation On Medical Devices Regulations Amendments, Medical Device Licences Guidance And IMDRF Table Of Contents Guidance

Canada Healthcare

SB

Smart & Biggar

See more

Webinars

See More

20 Jan 2026 | 3:00 PM

2026 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CBA In-House Lawyers

TC

CBA In-House Lawyers

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Healthcare

Santé Canada lance une consultation sur deux documents d'ébauche de lignes directrices sur les conditions pour les médicaments à usage humain et vétérinaire ainsi que les présentations de drogues basées sur des preuves prometteuses d'efficacité clinique

Conformément à ce que nous avons indiqué dans notre publication de décembre 2024, Santé Canada a publié ses modifications à apporter...

Canada Healthcare

SB

Smart & Biggar

Proposal For Modernizing Clinical Trial Framework Aims To Improve Access To New And Innovative Therapies In Canada

On December 20, 2025, Health Canada launched a consultation on modernizing the framework for clinical trials involving drugs for human use, including pharmaceuticals, biologics, radiopharmaceuticals, and cannabis.

Canada Healthcare

SB

Smart & Biggar

Une proposition de modernisation du cadre des essais cliniques pour favoriser l'accès à de nouvelles thérapies innovantes au Canada

Le 20 décembre 2025, Santé Canada a lancé une consultation sur la modernisation du cadre des essais cliniques visant les médicaments destinés à l'usage des humains...

Canada Healthcare

SB

Smart & Biggar

Abbott v. London Health Sciences Centre: Ontario Court Of Appeal Reaffirms The Authority Of Hospital Boards To Manage Resources

Canada Healthcare

OH

Osler, Hoskin & Harcourt LLP

Cancer-linked Drug And Product Lawsuits: Legal Pathways For Affected Patients

Canada Healthcare

SL

Siskinds LLP

Naming Natural Health Products: Branding In A Grey Zone

Canada Healthcare

ML

McMillan LLP

Health Canada Consultation On Two Draft Guidance Documents On Terms And Conditions For Human And Veterinary Drugs And Drug Submissions Based On Promising Evidence Of Clinical Efficacy

Canada Healthcare

SB

Smart & Biggar

OHA Ten Tips For Hospital Governance Compliance

Canada Commercial

BL

Borden Ladner Gervais LLP

Proposed New Requirements For Lithium-Ion Batteries In Consumer Products

Canada Consumer

GR

Gardiner Roberts LLP

See more

Food and Drugs Law

Federal Court Of Appeal Confirms BYOOVIZ Is Confusing With Novartis' BEOVU Trademark

On November 28, 2025, the Federal Court of Appeal (FCA) upheld an injunction against the use of the trademark BYOOVIZ for an ophthalmic biosimilar, confirming the application judge's finding that the mark is likely...

SB

Smart & Biggar

Santé Canada lance une consultation sur deux documents d'ébauche de lignes directrices sur les conditions pour les médicaments à usage humain et vétérinaire ainsi que les présentations de drogues basées sur des preuves prometteuses d'efficacité clinique

Conformément à ce que nous avons indiqué dans notre publication de décembre 2024, Santé Canada a publié ses modifications à apporter...

Canada Healthcare

SB

Smart & Biggar

Proposal For Modernizing Clinical Trial Framework Aims To Improve Access To New And Innovative Therapies In Canada

On December 20, 2025, Health Canada launched a consultation on modernizing the framework for clinical trials involving drugs for human use, including pharmaceuticals, biologics, radiopharmaceuticals, and cannabis.

Canada Healthcare

SB

Smart & Biggar

Une proposition de modernisation du cadre des essais cliniques pour favoriser l'accès à de nouvelles thérapies innovantes au Canada

Canada Healthcare

SB

Smart & Biggar

Cancer-linked Drug And Product Lawsuits: Legal Pathways For Affected Patients

Canada Healthcare

SL

Siskinds LLP

Legislative Update Report No. 2025-24 Le Bulletin D'actualités Législatives

Canada Government

OH

Osler, Hoskin & Harcourt LLP

Naming Natural Health Products: Branding In A Grey Zone

Canada Healthcare

ML

McMillan LLP

Liability Of Police Chiefs & Police Boards For Officer Misconduct: Rivard V. Ontario, 2025 ONCA 100

Canada Litigation

AH

Alexander Holburn Beaudin + Lang LLP

Health Canada Consultation On Two Draft Guidance Documents On Terms And Conditions For Human And Veterinary Drugs And Drug Submissions Based On Promising Evidence Of Clinical Efficacy

Canada Healthcare

SB

Smart & Biggar

See more

Life Sciences, Biotechnology & Nanotechnology

Santé Canada lance une consultation sur deux documents d'ébauche de lignes directrices sur les conditions pour les médicaments à usage humain et vétérinaire ainsi que les présentations de drogues basées sur des preuves prometteuses d'efficacité clinique

Conformément à ce que nous avons indiqué dans notre publication de décembre 2024, Santé Canada a publié ses modifications à apporter...

Canada Healthcare

SB

Smart & Biggar

Proposal For Modernizing Clinical Trial Framework Aims To Improve Access To New And Innovative Therapies In Canada

On December 20, 2025, Health Canada launched a consultation on modernizing the framework for clinical trials involving drugs for human use, including pharmaceuticals, biologics, radiopharmaceuticals, and cannabis.

Canada Healthcare

SB

Smart & Biggar

Une proposition de modernisation du cadre des essais cliniques pour favoriser l'accès à de nouvelles thérapies innovantes au Canada

Le 20 décembre 2025, Santé Canada a lancé une consultation sur la modernisation du cadre des essais cliniques visant les médicaments destinés à l'usage des humains...

Canada Healthcare

SB

Smart & Biggar

Cancer-linked Drug And Product Lawsuits: Legal Pathways For Affected Patients

Canada Healthcare

SL

Siskinds LLP

Naming Natural Health Products: Branding In A Grey Zone

Canada Healthcare

ML

McMillan LLP

Proposed New Requirements For Lithium-Ion Batteries In Consumer Products

Canada Consumer

GR

Gardiner Roberts LLP

How Is AI Transforming The Life Sciences Industry?

Canada Technology

TL

Torys LLP

What You Should Know About The Freestyle Libre 3 Recall

Worldwide Litigation

GP

Gluckstein Lawyers

VC Investment In Canada For Life Sciences Companies

Canada Healthcare

MT

McCarthy Tétrault LLP

See more

Latest Videos

See more

Bothwell V. London Health Sciences Centre, 2023 ONCA 323; Mental Health Injury Update (Video)

SB

SBA Lawyers LLP

Building A Credible Case On Damages With Monika Brunner And Roger Shoreman (Video)

GP

Gluckstein Lawyers

What's Next For Ontario's Public Health Care? (Video)

F

Fasken

The Legal Steps To Startups: Health & Life Science (Video)

PM

Parlee McLaws

From Discovery To Market: The Role Of IP Strategy In Drug Development (Video)

GW

Gowling WLG

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More